IPP Bureau
Lupin announces completion of pharmacovigilance inspection by USFDA
By IPP Bureau - March 27, 2023
The inspection included a comprehensive scrutiny of practices and procedures for reporting of adverse events of Lupin’s marketed products worldwide
Lupin announces successful completion of UK MHRA inspection of Pithampur facilities
By IPP Bureau - March 27, 2023
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
India ready to be voice of the global south in collaborative fight against TB: Dr. Mandaviya
By IPP Bureau - March 27, 2023
India has a pivotal role in eliminating TB
Ayush Ministry signs MoU with Department of ex-servicemen welfare
By IPP Bureau - March 27, 2023
Ayurveda OPD will be established in 10 ECHS Polyclinic/Dispensaries in various regions of India to cover all ECHS members on a voluntary basis
IIT Kanpur and University at Buffalo to enrich research in Biomedicine & Bioengineering
By IPP Bureau - March 25, 2023
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData
By IPP Bureau - March 25, 2023
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Quantumzyme receives patent for development of green catalyst in India
By IPP Bureau - March 25, 2023
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Zydus receives final approval from USFDA for Doxepin Hydrochloride Capsules USP, 150 mg
By IPP Bureau - March 25, 2023
Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety
Zydus receives final approval from USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg
By IPP Bureau - March 25, 2023
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
Lupin receives tentative approval from USFDA for Obeticholic Acid Tablets
By IPP Bureau - March 24, 2023
Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).
hubergroup India expands its support for rural healthcare
By IPP Bureau - March 24, 2023
hubergroup’s two newly added medical vans are dedicated to dental and eye care
PM chairs high-level meeting to asses situation of Covid-19 & Influenza
By IPP Bureau - March 23, 2023
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
PM to address One World TB Summit tomorrow
By IPP Bureau - March 23, 2023
PM to launch TB-Mukt Panchayat initiative; official pan-India rollout of a shorter TB Preventive Treatment and Family-centric care model for TB
Emmes acquires Essex Management
By IPP Bureau - March 23, 2023
Essex enriches and complements Emmes’ services
Medanta launches women and child care services in Gurugram
By IPP Bureau - March 23, 2023
Women of all ages will get round-the-clock access to comprehensive treatment
